In Sept.1-3,2025, Proxima Biotech made a notable appearance at CPHI China, the leading global pharmaceutical and healthcare ingredients exhibition, held in Shenzhen. As a key event for the biotech and pharmaceutical industries, CPHI China gathers thousands of exhibitors and buyers worldwide, offering a prime platform for networking, product launches, and industry collaboration.
Proxima present at CPHI 2025 in Shenzhen
At its booth, Proxima Biotech highlighted its flagship products, including high-purity natural vitamin E, algae-derived astaxanthin extracts, and eco-friendly biocatalytic ingredients—all aligned with the global trend of “clean label” and sustainable healthcare. The company’s team of R&D and sales experts were on-site to explain its proprietary biocatalytic extraction technology, which ensures low energy consumption, zero solvent residues, and compliance with EU and Chinese environmental standards. This drew strong interest from international buyers, especially those from Europe, Southeast Asia, and Latin America, who engaged in in-depth discussions about potential partnerships and bulk orders.
Beyond product showcases, Proxima’s representatives also attended industry forums at CPHI, gaining insights into the latest regulatory updates for biotech ingredients and emerging market demands. This participation not only boosted the company’s global visibility but also solidified its connections with key players in the pharmaceutical supply chain, paving the way for further expansion into international markets.
